Lipid Indicator for Cardiovascular Disorder Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting cardiovascular disorders through vibrational spectroscopy face challenges such as baseline shifts, non-linear backgrounds, and subtle spectral differences, leading to inaccuracies and inability to obtain reproducible data, necessitating a more accurate and rapid assessment method.
Innovation Solution
The method involves capturing unique signatures of lipid components using vibrational spectroscopy, transforming and comparing these signatures to obtain ratios, which indicate cardiovascular disorder risk, specifically focusing on ratios like LDL-carotenoid to LDL-total lipid and LDL-phospholipid to LDL-triglyceride ratios.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If vibrational spectroscopy is used to detect cardiovascular disorders, then rapid detection capability is achieved, but baseline shifts and non-linear backgrounds cause measurement inaccuracies
Solution Approach 1:
The patent applies preliminary action by performing baseline correction and normalization transformations on spectral data before analysis. The method pre-processes the spectral signatures to remove baseline shifts and non-linear backgrounds, ensuring accurate measurements are obtained before the actual detection process begins.
Solution Approach 2:
The patent utilizes parameter changes by transforming spectral data through mathematical operations such as baseline correction, normalization, and ratio calculations. These transformations change the parameters of the spectral data to eliminate interfering effects while preserving the diagnostic information, thereby improving measurement precision without sacrificing detection speed.
2Reliability
If traditional biomarker identification methods are used, then diagnostic information can be obtained, but the methods are time-consuming and lack rapid assessment capability
Solution Approach 1:
The patent applies the extraction principle by isolating and analyzing specific spectral regions and lipid components that are most relevant to cardiovascular disorder detection. Instead of analyzing entire complex biomarker profiles, the method extracts key spectral features and lipid signatures, enabling rapid assessment while maintaining diagnostic reliability.
Solution Approach 2:
The patent transforms complex spectral data into simplified ratio parameters (e.g., ratios of lipid components) that retain diagnostic information but can be processed and interpreted much faster. This parameter transformation enables rapid assessment without sacrificing the reliability of diagnostic conclusions.
3Loss of information
If spectral data is obtained from biological material, then diagnostic information is available, but subtle spectral differences lead to unwanted inaccuracies
Solution Approach 1:
The patent applies parameter changes by calculating ratios of spectral intensities at different wavenumbers corresponding to specific lipid components. This transformation amplifies subtle spectral differences into more pronounced ratio variations, improving the ability to detect and differentiate between health and disease states while retaining all relevant spectral information.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a reliable and accurate indication of cardiovascular disorder risk by identifying alterations in lipid component ratios, enabling early detection and assessment of cardiovascular disease.
Implementation Method 1
The invention generally relates to the field of vibrational spectroscopy and particularly to a method for identification of a lipid based indicator for cardiovascular disorder using vibrational spectroscopy
Data Source
AI summary
The invention provides a method for rapid detection of the viability of microorganisms. The method includes capturing a first unique signature with respect to a first lipid component, capturing a second unique signature with respect to a second lipid component, transforming each of the first lipid signatures and second lipid signatures to obtain amplified signatures, comparing the amplified signatures to obtain a first ratio and repeating the abovementioned steps at least one more time to obtain a second ratio. The alteration in the first ratio and the second ratio provides the indication for cardiovascular disorder.